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Mitochondrial inner membrane permeabilisation
enables mtDNA release during apoptosis
Joel S Riley1,2 , Giovanni Quarato3 , Catherine Cloix1,2, Jonathan Lopez1,2,† , Jim O’Prey1,2,
Matthew Pearson4, James Chapman5, Hiromi Sesaki6, Leo M Carlin1,2 , João F Passos5,7,
Ann P Wheeler4, Andrew Oberst8,9, Kevin M Ryan1,2 & Stephen WG Tait1,2,*
Abstract
During apoptosis, pro-apoptotic BAX and BAK are activated, caus-
ing mitochondrial outer membrane permeabilisation (MOMP),
caspase activation and cell death. However, even in the absence of
caspase activity, cells usually die following MOMP. Such caspase-
independent cell death is accompanied by inflammation that
requires mitochondrial DNA (mtDNA) activation of cGAS-STING
signalling. Because the mitochondrial inner membrane is thought
to remain intact during apoptosis, we sought to address how
matrix mtDNA could activate the cytosolic cGAS-STING signalling
pathway. Using super-resolution imaging, we show that mtDNA is
efficiently released from mitochondria following MOMP. In a
temporal manner, we find that following MOMP, BAX/BAK-
mediated mitochondrial outer membrane pores gradually widen.
This allows extrusion of the mitochondrial inner membrane into
the cytosol whereupon it permeablises allowing mtDNA release.
Our data demonstrate that mitochondrial inner membrane perme-
abilisation (MIMP) can occur during cell death following BAX/BAK-
dependent MOMP. Importantly, by enabling the cytosolic release
of mtDNA, inner membrane permeabilisation underpins the
immunogenic effects of caspase-independent cell death.
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Introduction
To initiate cell death, intrinsic or mitochondrial apoptosis requires
mitochondrial outer membrane permeabilisation, or MOMP (Tait &
Green, 2013). MOMP causes the release of mitochondrial intermem-
brane space proteins, including cytochrome c, that activate caspase
proteases leading to apoptosis. Nevertheless, irrespective of caspase
activity, cells typically do not survive following widespread MOMP,
defining it as a point-of-no-return (Haraguchi et al, 2000; Ekert et al,
2004; Tait et al, 2010). Because of this central role in dictating cell
fate, MOMP is tightly controlled, primarily via pro- and anti-apop-
totic members of the BCL-2 protein family (Lopez & Tait, 2015).
Under homeostatic conditions, anti-apoptotic BCL-2 family members
(e.g. BCL-2, BCL-xL, MCL-1) block the pro-apoptotic actions of BAX
and BAK. Following an apoptotic trigger, BAX and BAK are acti-
vated, leading to their oligomerisation in the mitochondrial outer
membrane and MOMP (Wei et al, 2001; Cosentino & Garcia-Saez,
2017).
Mitochondrial apoptosis is considered a non-inflammatory form
of cell death, allowing the host to quickly and efficiently clear away
dead cell corpses without provoking an immune response
(Arandjelovic & Ravichandran, 2015). Recently, others and
ourselves have shown that caspase activity is essential for the non-
inflammatory nature of mitochondrial apoptosis; if caspase activity
is blocked following MOMP, cell death still occurs, but a type I inter-
feron (IFN) response and NF-jB activation ensues (Rongvaux et al,
2014; White et al, 2014; Giampazolias et al, 2017). This leads to
pro-inflammatory cytokine production and an immune response
towards the dying cell that can initiate anti-tumour immunity
(Giampazolias et al, 2017). Therefore, as proposed by others, a
main function of apoptotic caspase activity may be to silence
inflammation during cell death (Martin et al, 2012).
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The ability of MOMP to activate inflammation and a type I IFN
response requires recognition of mtDNA by the cytosolic cGAS-
STING DNA sensing pathway (Rongvaux et al, 2014; White et al,
2014; Giampazolias et al, 2017). However, it is challenging to recon-
cile how matrix localised mtDNA can activate the cytosolic cGAS-
STING DNA sensing pathway since the mitochondrial inner
membrane is thought to remain intact during apoptosis (von Ahsen
et al, 2000; Waterhouse et al, 2001). Given this paradox, we set out
to define how mtDNA could activate cGAS-STING signalling. Using
a variety of high-resolution imaging techniques, we find that follow-
ing the onset of MOMP, BAX/BAK-mediated pores widen to allow
the extrusion of newly unstructured inner membrane. Under condi-
tions of caspase inhibition, the extruded inner membrane perme-
abilises facilitating mtDNA release into the cytoplasm, allowing it to
activate cGAS-STING signalling and IFN synthesis. Unexpectedly,
our data demonstrate that the mitochondrial inner membrane can
undergo permeabilisation during cell death. Importantly, by releas-
ing mtDNA, mitochondrial inner membrane permeabilisation, or
MIMP, enables cell death-associated inflammation.
Results
mtDNA is released from mitochondria following MOMP
To visualise mtDNA dynamics during apoptosis, we used super-
resolution Airyscan confocal microscopy. Importantly, this
provides sufficient resolution to allow the visualisation of the mito-
chondrial outer membrane and matrix-resident molecules (such as
TFAM containing mtDNA nucleoids) as distinct entities under sub-
diffraction-limiting conditions. As expected, in healthy U2OS cells,
dual immunostaining of the mitochondria outer membrane protein
TOM20 and DNA revealed that mtDNA nucleoids are contained
within mitochondria surrounded by a continuous outer membrane
(Fig 1A). To engage mitochondrial apoptosis, U2OS cells were
treated with the BH3-mimetic ABT-737, which inhibits BCL-xL,
BCL-2 and BCL-w (Oltersdorf et al, 2005) together with actino-
mycin D (ActD, to inhibit transcription of labile MCL-1), in the
presence or absence of pan-caspase inhibitor qVD-OPh. To assess
cell viability, U2OS cells were imaged using IncuCyte live-cell
imaging and SYTOX Green uptake or assessed for long-term clono-
genic survival (Fig EV1A and B). Consistent with engagement of
mitochondrial apoptosis, ABT-737/ActD co-treatment rapidly and
synchronously induced cell death (Fig EV1A). Co-treatment with
caspase inhibitor qVD-OPh prevented cell death in the short term
(Fig EV1A) but failed to allow long-term clonogenic survival
(Fig EV1B), consistent with widespread MOMP being a point-of-
no-return. Under identical MOMP-inducing conditions, U2OS cells
were immunostained with anti-TOM20 and DNA antibodies to
visualise mitochondrial outer membrane integrity and mtDNA-
containing nucleoids, respectively (Fig 1B). Alternatively, U2OS
cells were immunostained with anti-TOM20 and cytochrome c anti-
bodies to determine MOMP (Fig EV1C and D). Under these condi-
tions, over 90% of U2OS cells underwent MOMP, as determined
by loss of mitochondrial cytochrome c staining (Fig EV1C and D).
Specifically following ABT-737/ActD treatment, under caspase-
inhibited conditions, permeabilisation of the mitochondrial outer
membrane was observed in over 80% of cells, as evidenced by
discontinuous, crescent-like TOM20 immunostaining (Fig 1B and
C). Strikingly, mtDNA displayed cytosolic re-localisation in cells
that had undergone MOMP under caspase-inhibited conditions
(Fig 1B). Under these conditions, over 80% of cells displayed
mtDNA cytosolic release (Fig 1C) and, on average per cell, over
80% of mtDNA displayed cytosolic localisation (Fig 1D). A similar
pattern of mtDNA cytosolic localisation and mitochondrial outer
membrane permeabilisation was also observed in E1A/Ras trans-
formed MEF specifically following ABT-737/ActD/qVD-OPh treat-
ment (Fig 1E). Both cytosolic and mitochondrial mtDNA structures
were of similar size, suggesting cytosolic re-localisation of mtDNA-
containing nucleoids. To determine whether mtDNA re-localisation
was dependent on MOMP, we used CRISPR-Cas9 genome editing
to delete BAX and BAK, two proteins essential for MOMP (Wei
et al, 2001) either singly or together (Fig 1F). Only combined dele-
tion of BAX and BAK in U2OS cells prevented MOMP and cell
death following ABT-737/S63845 treatment (Figs 1G and EV1E).
Under identical conditions, dual immunostaining of TOM20 and
DNA demonstrated that combined deletion of BAX/BAK, but not
of either alone, prevented cytosolic release of mtDNA following
ABT-737/S63845/qVD-OPh treatment (Fig 1H and I). Collectively,
these data show that matrix localised mtDNA is released from
mitochondria following BAX/BAK-dependent MOMP under
caspase-inhibited conditions.
Mitochondrial release of mtDNA correlates with a STING-
dependent interferon response
We next investigated an association between mitochondrial
mtDNA release and activation of a STING-dependent interferon
response. For this purpose, we used SVEC 4–10 murine endothelial
cells, which we have previously shown have an intact cGAS-
STING signalling pathway (Giampazolias et al, 2017). To induce
rapid mitochondrial apoptosis, SVEC cells were treated with ABT-
737 together with the MCL-1 inhibitor S63845 (Kotschy et al,
2016), and cell death was monitored by SYTOX Green uptake and
IncuCyte live-cell imaging (Fig 2A). Combined ABT-737/S63845
treatment led to rapid cell death that was inhibited by addition of
qVD-OPh, consistent with engagement of mitochondrial apoptosis.
Following 3 h of ABT-737/S63845 treatment in the presence of
qVD-OPh, cells were immunostained with anti-TOM20 and DNA
antibodies to visualise mitochondrial outer membrane integrity
and mtDNA-containing nucleoids (Fig 2B). Similar to other cell
types, mitochondrial release of mtDNA was detected. We next
investigated whether a STING-dependent transcriptional interferon
response was being activated under these conditions using qRT–
PCR. Following engagement of caspase-independent cell death
(CICD), various IFN response genes (Ifnb1, Irf7 and Oasl1) were
upregulated (Fig 2C). ABT-737/S63845-induced transcriptional
upregulation of Ifnb1 was greatly increased upon inhibition of
caspase function by qVD-OPh addition (Fig 2D). Deletion of
STING, through CRISPR/Cas9 genome editing (Fig 2E), blocked
Ifnb1 upregulation during CICD, consistent with previous findings
of others and ourselves (Fig 2F; Giampazolias et al, 2017;
Rongvaux et al, 2014; White et al, 2014). Combined deletion of
BAX and BAK, but not of either alone, also inhibited Ifnb1 upregu-
lation following ABT-737/S63845/qVD-OPh treatment, demonstrat-
ing a requirement for MOMP (Fig 2G and H). These data
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Figure 1. mtDNA is released from mitochondria following MOMP in a BAX/BAK-dependent manner.
A Fixed super-resolution Airyscan images of U2OS cells immunostained with anti-TOM20 (green) and anti-DNA (red) antibodies. Scale bar = 10 lm. Representative
images from three independent experiments.
B Airyscan images of U2OS cells treated with 10 lM ABT-737, 1 lM ActD and 20 lM qVD-OPh for 3 h, immunostained with anti-TOM20 and anti-DNA antibodies. Scale
bar = 10 lm. Representative images from three independent experiments.
C Quantification of cells exhibiting > 10% mtDNA release following treatment with 10 lM ABT-737, 1 lM ActD and 20 lM qVD-OPh. Data are expressed as
mean  SD from three independent experiments and analysed by Student’s t-test.
D Quantification of the extent of mitochondrial DNA (mtDNA) nucleoid release per cell following treatment with 10 lM ABT-737, 1 lM ActD and 20 lM qVD-OPh. Data
are expressed as mean  SD from two independent experiments and analysed by Student’s t-test.
E Airyscan images of MEF cells untreated or treated with 10 lM ABT-737 and 20 lM qVD-OPh for 3 h, immunostained with anti-TOM20 and anti-DNA antibodies.
Scale bar = 10 lm. Representative images from three independent experiments.
F BAX and BAK expression levels in U2OS cells with CRISPR-Cas9-mediated deletion of BAX, BAK or BAX/BAK.
G U2OS cells with BAX, BAK or BAX/BAK deletion by CRISPR-Cas9 treated with 10 lM ABT-737 and 2 lM S63845 and analysed for cell viability using an IncuCyte live-
cell imager and SYTOX Green exclusion. Data are expressed as mean  SEM, representative of three independent experiments, and have been normalised to starting
confluency.
H Airyscan images of U2OS (i) control cells or with CRISPR-Cas9-mediated deletion of either (ii) BAX, (iii) BAK or (iv) BAX and BAK treated with 10 lM ABT-737, 2 lM
S63845 and 20 lM qVD-OPh for 3 h. Scale bar = 10 lm. Representative images from three independent experiments.
I Quantification of mtDNA nucleoid release per cell in U2OS EMPTYCRISPR, BAXCRISPR, BAKCRISPR and BAX/BAKCRISPR cells. Data are expressed as mean  SD from three
independent experiments and analysed using Student’s t-test.
Source data are available online for this figure.
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demonstrate a correlation between the release of mtDNA and acti-
vation of a STING-dependent interferon response.
Mitochondrial nucleoids are extruded via expanding outer
membrane pores
Our data suggests that mtDNA nucleoids are released from mito-
chondria during following MOMP under caspase-inhibited condi-
tions. To investigate this further, U2OS cells were treated with ABT-
737/S63845/qVD-OPh for 3 h to induce CICD, then simultaneously
stained for mtDNA and TFAM—a nucleoid-resident protein
(Fig 3A). The mitochondrial outer membrane was visualised using a
SNAP-tag Omp25 fusion protein and the far-red fluorophore Janelia
Fluor 646 (JF646; referred to as JF646-MOM; Grimm et al, 2015; Kata-
jisto et al, 2015). As expected, in healthy mitochondria, DNA co-
localised with TFAM within the mitochondria (Fig 3A). Importantly,
during CICD, both DNA and TFAM co-localised outside the mito-
chondria, consistent with release of mtDNA-containing nucleoids.
We next investigated the dynamics of mtDNA re-localisation by
live-cell imaging. Because live-cell imaging of mtDNA using Pico-
Green was not possible due to photobleaching, we monitored the
localisation of mClover-fused TFAM. The mitochondrial outer
membrane was visualised using JF646-MOM. As expected, TFAM-
mScarlet localised to the mitochondrial matrix, co-localising with
mtDNA (Fig EV2A). U2OS cells expressing JF646-MOM and TFAM-
mClover were induced to undergo MOMP  qVD-OPh and imaged
by live-cell imaging (Fig EV2B, Videos EV1–EV3). Under caspase-
proficient conditions, following MOMP, the cell rapidly shrunk and
detached, consistent with engagement of apoptosis (Video EV1).
Under caspase-inhibited conditions, after ABT-737 treatment,
TFAM-mClover was released into the cytosol, consistent with our
earlier analysis of mtDNA (Fig EV2B, Videos EV2 and EV3). Finally,
we investigated the kinetics of TFAM-mClover release and MOM
pore widening relative to MOMP. U2OS cells expressing TFAM-
mClover, Omi-mCherry and JF646-MOM were treated with ABT-737
in combination with the MCL1 inhibitor S63845 in the presence of
qVD-OPh then subject to live-cell imaging (Fig 3B, Video EV4).
Analysis of individual mitochondria demonstrated, in a sequential
manner, that mitochondrial release of Omi-mCherry (denoting
MOMP) occurs prior to the visual appearance and widening of
MOM pores (Fig 3C and D), finally followed by TFAM-mClover
release. Importantly, not all mitochondria following MOMP released
TFAM and, when it did occur, the time between MOMP and release
of TFAM was highly variable, ranging from 10 to 100 min
(Fig EV2C and D).
Mitochondrial inner membrane permeabilisation allows mtDNA
release into the cytosol
Thus far, our data demonstrate that mtDNA/TFAM complexes
relocalise beyond the mitochondrial outer membrane; however,
the integrity of the inner mitochondrial membrane (IMM) or locali-
sation of mtDNA relative to the IMM was not determined. To
investigate this, U2OS cells were treated with ABT-737/ActD in the
presence of qVD-OPh, immunostained for apoptosis-inducing factor
(AIF) and DNA (to visualise the IMM and mtDNA, respectively)
and analysed by Airyscan imaging (Fig 4A, Videos EV5 and EV6).
In healthy cells, the majority of mtDNA signal was within AIF
immunostained structures, in line with AIF being inner membrane
localised and mtDNA residing within the matrix (Fig 4A, Video
EV5). Importantly, following MOMP (ABT-737/ActD/qVD-OPh
treatment), mtDNA was found to localise in the cytoplasm, outside
the inner membrane (AIF immunostained structures; Fig 4A, Video
EV6). This suggests that mtDNA can pass beyond the inner
membrane during caspase-independent cell death (CICD). To
investigate this further, we simultaneously imaged the MOM, IMM
and mtDNA during cell death. U2OS cells stably expressing JF646-
MOM were treated with ABT-737/ActD/qVD-OPh and then
immunostained with anti-AIF and anti-DNA antibodies to detect
the MOM, IMM and mtDNA, respectively. Cells were analysed by
Airyscan imaging and 3D-structured illumination microscopy (3D-
SIM; Figs 4B and EV3A). 3D-SIM analysis demonstrated re-localisa-
tion of both AIF and mtDNA beyond the mitochondrial outer
membrane specifically following MOMP (Fig EV3A). Consistent
with this, Airyscan analysis also demonstrated AIF and mtDNA re-
localisation beyond the mitochondrial outer membrane specifically
following MOMP (Fig 4B). 3D-Imaris-based analysis revealed
mtDNA and inner membrane protrusion through the mitochondrial
outer membrane following MOMP (Figs 4C and EV3B), in line with
earlier live-cell analysis of TFAM-mClover, showing its extrusion
▸Figure 2. MOMP-induced mtDNA release initiates a cGAS-STING-dependent type I interferon response.A SVEC cells treated with 10 lM ABT-737 and 10 lM S63845  20 lM qVD-OPh. Cell viability was analysed using an IncuCyte live-cell imager and SYTOX Green
exclusion. Data are expressed as mean  SEM, representative of two independent experiments.
B Airyscan images of SVEC cells treated with 10 lM ABT-737, 10 lM S63845 and 20 lM qVD-OPh for 3 h, immunostained with anti-TOM20 and anti-DNA antibodies.
Scale bar = 10 lm. Representative images from three independent experiments.
C Ifnb1, Irf7 and Oasl1 mRNA expression in SVEC cells treated with 10 lM ABT-737, 10 lM S63845 and 20 lM qVD-OPh for 3 h. Data are representative of three
independent experiments.
D Ifnb1 mRNA expression in SVEC cells treated with 10 lM ABT-737, 10 lM S63845  20 lM qVD-OPh for 2 h. Data are representative of two independent
experiments.
E STING expression in CRISPR-Cas9-mediated STING-deleted SVEC cells using three independent sgRNA sequences.
F Ifnb1 mRNA expression in STING CRISPR-Cas9-deleted SVEC cells treated with 10 lM ABT-737, 10 lM S63845 and 20 lM qVD-OPh for 3 h. Data are representative of
two independent experiments.
G BAX and BAK expression in SVEC cells harbouring CRISPR-Cas9-mediated deletion of BAX, BAK or BAX/BAK.
H Ifnb1 mRNA expression in BAX, BAK or BAX/BAK CRISPR-Cas9-deleted SVEC cells treated with 10 lM ABT-737, 10 lM S63845 and 20 lM qVD-OPh for 3 h. Data are
representative of two independent experiments.
Source data are available online for this figure.
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(Fig 3B, Videos EV2–EV4). In agreement with our earlier data,
mtDNA also relocalised outside the mitochondrial outer membrane
following MOMP, either associated or not with the inner
membrane (Fig EV3B). Next, we aimed to visualise this by live-cell
microscopy. To this end, we co-expressed JF646-MOM, AIF (1-90)-
mClover and TFAM-mScarlet in U2OS cells to visualise the MOM,
IMM and matrix, respectively. To induce CICD, cells were treated
with ABT-737/S63845 in the presence of qVD-OPh and analysed
by live-cell microscopy (Fig 4D, Video EV7). This approach
enabled specific visualisation of the MOM and IMM; TFAM loca-
lised within the IMM, consistent with its matrix localisation
(Fig 4D, 0 min). Similar to previous results, over time large pores
in the MOM appeared, preceding extrusion of IMM enclosed
matrix (Fig 4D, 60 min). Finally, TFAM was found outside the
IMM (Fig 4D, 120 min). Together, these data suggest that follow-
ing MOMP, the mitochondrial inner membrane is extruded through
the permeabilised outer membrane. Mitochondrial inner membrane
permeabilisation, or MIMP, can then occur, allowing mtDNA
egress into the cytosol.
Mitochondrial mtDNA release is independent of mitochondrial
dynamics and permeability transition
Various studies have shown that upon MOMP the GTPase DRP-1
promotes mitochondrial network fragmentation and inner
membrane remodelling (Desagher & Martinou, 2000; Frank et al,
2001; Estaquier & Arnoult, 2007). Potentially, inner membrane
remodelling and/or mitochondrial fission at the point of MOMP
might facilitate MIMP and mtDNA release. To investigate a role for
DRP-1, we used conditional Drp1fl/fl MEFs, using adenovirus
expressing Cre recombinase to effectively delete DRP-1 protein
(Fig EV4A; Wakabayashi et al, 2009). Wild-type or DRP-1-deleted
MEF were then treated with ABT-737/ActD to engage
mitochondrial apoptosis. Cells were imaged using IncuCyte live-
cell imaging and SYTOX Green uptake. ABT-737/ActD treatment
effectively induced apoptosis to a similar extent irrespective of
DRP-1 expression (Fig EV4B). In the presence of caspase inhibitor,
samples were immunostained for TOM20 and mtDNA, and identi-
fied as having undergone MOMP by loss of mitochondrial cyto-
chrome c staining. 3D images were generated from Z-stacks of
high-resolution images and quantified for mtDNA release (Fig 5A
and B). In control samples, DRP-1-deleted cells displayed hyper-
fused mitochondria, as expected (Fig 5A). Importantly, the extent
of mtDNA release in cells that had undergone MOMP failed to
reveal a difference between wild-type and DRP-1-deficient cells
(Fig 5A and B). To investigate a role for mitochondrial fission
using an alternative method, we investigated whether mitochon-
dria that have already undergone fission could release mtDNA
upon MOMP. To this end, U2OS MCL-1CRISPR cells were pre-incu-
bated with carbonyl cyanide m-chlorophenyl hydrazine (CCCP) to
induce extensive mitochondrial fission and then treated to undergo
MOMP by addition of ABT-737 in the presence of qVD-OPh. Cells
were immunostained for TOM20 and mtDNA, then analysed by
Airyscan microscopy. As expected, CCCP treatment induced exten-
sive mitochondrial fragmentation (Fig 5C). Importantly, induced
mitochondrial fission had no effect on MOMP-induced mtDNA
release, consistent with the lack of requirement for DRP-1. To
further define MIMP, we adapted an assay to measure mitochon-
drial release of matrix calcein relative to MOMP by live-cell imag-
ing (Bonora et al, 2016). We reasoned that should the inner
membrane become permeable, Co2+ would be free to enter the
matrix and quench matrix-located calcein, enabling of detection of
increased permeability in real time. To simultaneously visualise
MOMP, we expressed Omi-mCherry which resides in the mito-
chondrial inner membrane space (Tait et al, 2010). U2OS cells
loaded with calcein-AM and Co2+ were treated with ABT-737/
◀ Figure 3. mtDNA extrusion occurs through expanding outer membrane pores.A Airyscan images of U2OS cells stably expressing JF646-MOM (magenta) treated with 10 lM ABT-737, 2 lM S63845 and 20 lM qVD-OPh for 3 h, immunostained with
anti-DNA and anti-TFAM antibodies. Scale bar = 10 lm. Representative images from two independent experiments.
B Live-cell Airyscan imaging of U2OS cells stably expressing JF646-MOM (magenta) and Omi-mCherry (red) and transiently expressing TFAM-mClover (green). Cells were
treated with 10 lM ABT-737, 10 lM S63845 and 20 lM qVD-OPh at t = 0. Arrows denote mitochondria which show TFAM release. Scale bar = 10 lm. See Video EV4.
Numbers indicate time in minutes.
C Zoom of a single mitochondrion from Fig 3B and Video EV4. Scale bar = 1 lm. Numbers indicate time in minutes.
D Loss of Omi intensity as assessed by standard deviation of the Omi signal across the cell and pore size plotted against time. Data are from three mitochondria (pore
size) or three cells (Omi release) from two independent experiments and are expressed as mean  SEM.
Source data are available online for this figure.
▸Figure 4. Mitochondrial inner membrane permeabilisation allows mtDNA release into the cytosol.A Maximum intensity projection of Airyscan z-stack data of U2OS cells treated with 10 lM ABT-737, 1 lM ActD and 20 lM qVD-OPh for 3 h. Cells were immunostained
with anti-AIF (IMM) and anti-DNA antibodies. Z-stack data were 3D-rendered in Imaris and mtDNA nucleoid inside and outside the AIF signal were visualised. Scale
bar = 5 lm. See Videos EV5 and EV6. Representative images from three independent experiments.
B Airyscan images of U2OS cells stably expressing JF646-MOM (magenta) treated with 10 lM ABT-737, 1 lM ActD and 20 lM qVD-OPh for 3 h and immunostained with
anti-DNA (red) and anti-AIF (IMM, green) antibodies. Scale bar = 10 lm. Representative images from three independent experiments.
C Imaris 3D-renderings of MOM (magenta), AIF (green) and DNA (red) from U2OS cells treated as in (B).
D U2OS cells stably expressing JF646-MOM (magenta) and transiently expressing TFAM-mScarlet (red) and AIF (1-90)-mClover (green) live-cell imaged by Airyscan. Cells
were treated with 10 lM ABT-737, 2 lM S63845 and 20 lM qVD-OPh at t = 0. Scale bar = 10 and 2 lm for zooms. See Video EV7. Representative images from two
independent experiments. Numbers indicate time in minutes. Arrowheads indicate instances of released TFAM.
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S63845 in the presence of qVD-OPh and imaged by confocal micro-
scopy (Fig 5D and Video EV8). In healthy cells, mitochondrial
localised calcein persisted, consistent with the mitochondrial IMM
being impermeable (Fig EV4D). However, following MOMP (de-
fined by mitochondrial release of Omi-mCherry) the matrix calcein
signal was rapidly lost within minutes (mean time of 10 min)
following MOMP (Fig 5D and E, and Video EV8). Loss of calcein
signal was not blocked by co-treatment with the cyclophilin D
inhibitor cyclosporin A (CsA; Fig EV4E and Video EV9). This
demonstrates, at early time points following MOMP, the mitochon-
drial inner membrane increases permeability to small ions.
Prolonged opening of the mitochondrial permeability transition
pore (MPTP) causes mitochondrial swelling leading to mitochon-
dria rupture (Izzo et al, 2016). We therefore investigated whether
MPTP contributed to mtDNA release. Wild type and MEFs deleted
for cyclophilin D (Fig EV4C; a critical component of the MPTP;
Baines et al, 2005; Nakagawa et al, 2005) were treated with ABT-
737/ActD/qVD-OPh to engage MOMP and then immunostained for
DNA and TOM20, to visualise mtDNA and the mitochondrial outer
membrane, respectively. Importantly, a similar extent of mtDNA
release was observed between WT and CypD/ cells, ruling out a
critical role for MPTP in mtDNA release (Fig 5F and G). Collec-
tively, these data show that MIMP, enabling the release of mtDNA,
is independent of both mitochondria dynamics and MPTP.
Mitochondrial inner membrane is extruded through expanding
BAX pores
We next sought to understand how the inner membrane breaches
the outer membrane, permitting mtDNA release. It is well estab-
lished that during apoptosis BAX and BAK form oligomers on the
mitochondrial outer membrane leading to MOMP (Cosentino &
Garcia-Saez, 2017). We therefore investigated the relationship
between BAX activation, MOMP and MIMP through live-cell imag-
ing. To this end, mCherry-BAX was expressed in BAX/BAK-deleted
U2OS cells together with JF646-MOM and TFAM-mClover. Cells were
treated with ABT-737/S63845 in the presence of qVD-OPh to induce
MOMP then analysed by live-cell imaging (Figs 6A and EV5A, Video
EV10). Consistent with our earlier data, following treatment, pores
in the MOM occurred that gradually increased in size (Figs 6A and
EV5A, Video EV10). Combined analysis of the MOM, TFAM and
BAX showed that TFAM is commonly extruded from large MOM
openings that are decorated by BAX puncta. This suggests that
growing BAX-mediated pores in the mitochondrial outer membrane
enables extrusion of the mitochondrial inner membrane. To investi-
gate this further, we treated U2OS MCL1CRISPR cells (which die in a
rapid and synchronous manner in response to ABT-737) expressing
JF646-MOM and TFAM-mClover with ABT-737 in the presence of
qVD-OPh and immunostained with antibody recognising active BAX
(6A7; Hsu & Youle, 1997). In line with previous findings, we found
that during MOMP, the MOM becomes decorated in activated BAX
punctate structures (Figs 6B and EV5B). 3D images were generated
from Z-stacks of super-resolution images (Figs 6C and EV5C). These
images frequently showed translocation of TFAM-mClover through
the mitochondrial outer membrane at sites demarked by active BAX
staining. We next investigated the inner membrane relative to BAX
localisation and outer membrane opening. U2OS cells expressing
JF646-MOM were treated with ABT-737/S63845 in the presence of
qVD-OPh and immunostained for active BAX (6A7) and AIF to
detect the inner membrane (Figs 6D and EV5D). Specifically follow-
ing treatment, the inner membrane was found to be extruded via
active BAX decorated pores. This was supported by 3D-Imaris-based
analysis (Figs 6E and EV5E). These data support a model, whereby
following MOMP the mitochondrial inner membrane can be
extruded through BAX-mediated outer membrane pores. Once in the
cytoplasm, the inner membrane can permeabilise, allowing mtDNA
to activate cGAS-STING signalling.
Discussion
Following apoptotic mitochondrial permeabilisation, mtDNA acti-
vates cGAS-STING-dependent interferon synthesis under caspase-
inhibited conditions (Rongvaux et al, 2014; White et al, 2014;
Giampazolias et al, 2017). Here, we investigated how matrix loca-
lised mtDNA could activate cytosolic cGAS-STING signalling, given
that their separate subcellular localisation. We find that under
caspase-inhibited conditions, BAX/BAK-mediated MOMP allows
extrusion of the mitochondrial inner membrane into the cytoplasm.
Unexpectedly, the extruded inner membrane eventually perme-
abilises leading to cytosolic release of mtDNA where it can activate
cGAS-STING signalling. By doing so, mitochondrial inner membrane
▸Figure 5. mtDNA release is independent of fission and the mitochondrial permeability transition pore.A Maximum intensity projection of z-stack Airyscan images of Drp1fl/fl MEFs with induced Drp1 deletion by AdCre lentiviral particles. Cells were treated with 10 lM
ABT-737, 1 lM ActD and 20 lM qVD-OPh for 3 h and immunostained with anti-TOM20 (MOM) and anti-DNA antibodies. Zooms show Imaris 3D reconstructions of
surface (MOM, TOM20) and spots (DNA) to show the extent of mtDNA release. Scale bar = 10 lm. Representative images from two independent experiments.
B Quantification of mtDNA release per cell in Wt or Drp1-deleted cells. Data are from two independent experiments and are expressed as mean  SD. Data were
analysed by Student’s t-test.
C U2OS MCL1CRISPR cells were pre-treated with 10 lM CCCP and 20 lM qVD-OPh for 30 min to induce mitochondrial fragmentation after which treatment was
changed to 10 lM ABT-737 and 20 lM qVD-OPh. After 3 h, cells were fixed and immunostained with anti-TOM20 and anti-DNA antibodies. Zooms show highlighted
areas. Scale bar = 10 lm. Representative images from three independent experiments.
D Images from time-lapse live-cell imaging of U2OS cells loaded with calcein-AM and CoCl2 and treated with 10 lM ABT-737/S63845/qVD-OPh at t = 0. Scale
bar = 10 lm. See Video EV8. Representative images from three independent experiments. Numbers indicate time in minutes.
E Quantification of calcein release from mitochondria relative to Omi release. Data are from three independent experiments.
F Maximum intensity projections of z-stack Airyscan images of Wt and CypD/ MEFs. Cells were treated with 10 lM ABT-737, 1 lM ActD and 20 lM qVD-OPh for 3 h
and immunostained for TOM20 (MOM) and DNA. Scale bar = 10 lm. Representative images from two independent experiments.
G Quantification of mtDNA release per cell in Wt or CypD-deleted cells. Data are from two independent experiments and are expressed as mean  SD. Data were
analysed by Student’s t-test.
Source data are available online for this figure.
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permeabilisation or MIMP supports the immunogenic effects of
caspase-independent cell death.
Surprisingly, our data show that mitochondrial inner membrane
can permeabilise subsequent to BAX/BAK-mediated MOMP. We
found that over time, following MOMP (defined by release of
Omi-mCherry), visible and widening pores appeared in the MOM
through which the inner membrane is extruded (Figs 3C and D, and
4). Interestingly, active BAX was found to localise at the edge of the
widening MOM pores through which the inner membrane extrudes
(Fig 6). This is reminiscent of recent studies showing that during
apoptosis, BAX-rings border visible pores in the mitochondrial outer
membrane (Grosse et al, 2016; Salvador-Gallego et al, 2016). Over
time, we observed these MOM pores gradually widen enabling inner
membrane extrusion. Coupling our data to recent findings demon-
strating variation in BAX-ring size (Salvador-Gallego et al, 2016) as
well as wide variation in BAX-mediated pore size (Dewson et al,
2012; Czabotar et al, 2013) strongly suggests that BAX-mediated
pores are dynamic and grow over time. This is consistent with
growing BAX pores previously detected during BAX-mediated lipo-
somal permeabilisation (Bleicken et al, 2013).
How the inner membrane eventually permeabilises remains
unclear. Our data argue against any role for mitochondrial perme-
ability transition or mitochondrial dynamics in the process. Inner
membrane permeabilisation occurs considerably later (1 h) than
MOMP, with less penetrance and in apparent stochastic manner
(Fig 5E). As such, whether MIMP occurs in a regulated manner is
unclear. Recently, McArthur, Kile and colleagues also described
inner membrane permeabilisation during apoptosis and CICD
enabling release of mtDNA (McArthur et al, 2018). The extent of
MIMP they observed was significantly less than us, potentially
reflecting cell-type differences in the propensity of mitochondria to
undergo MIMP. Interestingly, we detected increased permeability of
the mitochondrial inner membrane to small ions, shortly following
the onset of MOMP. This increased permeability may explain the
transient drop in inner membrane potential immediately following
MOMP previously reported by others (Waterhouse et al, 2001).
What drives this increased permeability is unknown but we reason
it must be transient, since many studies have shown mitochondrial
inner membrane potential can be maintained post-MOMP under
caspase-inhibited conditions (Bossy-Wetzel et al, 1998; von Ahsen
et al, 2000; Waterhouse et al, 2001; Huber et al, 2011). While inner
membrane extrusion and MIMP can be temporally separated from
mtDNA release, it is possible that the increased permeability of the
inner membrane we observe following MOMP may precipitate these
later events.
Following MOMP, our ability to detect inner membrane extrusion
and MIMP during cell death was dependent upon inhibition of
caspase function. This contrasts with findings from McArthur, Kile
and colleagues, whom could detect mtDNA release during
(caspase-dependent) apoptosis (McArthur et al, 2018). Notably,
induction of mitochondrial apoptosis under caspase-proficient
conditions also led to an increase in IFN-b mRNA, albeit not to the
same extent as under conditions of CICD (Fig 2D). We therefore
think it likely that our inability to visualise MIMP during apoptosis
relates to the kinetics of apoptotic cell death being much more rapid
than MIMP, such that rounding and detachment of apoptotic cells
made them impossible to image over a longer period (Video EV1).
Even if MIMP does occur during apoptosis, its functional effects
may be limited due to rapid loss of cell viability coupled to the
strong inhibitory effects of caspase activity on protein translation
(Clemens et al, 2000). Indeed, we and others have shown that
MOMP has pro-inflammatory effects only under caspase-inhibited
conditions (Rongvaux et al, 2014; White et al, 2014; Giampazolias
et al, 2017). Nevertheless, physiological engagement of MIMP, lead-
ing to mtDNA release and interferon synthesis, might be expected in
cell types deficient or defective in caspase activity such as cardiomy-
ocytes and sympathetic neurons following MOMP (Potts et al, 2005;
Wright et al, 2007; Potts et al, 2005; Wright et al, 2007). Another
possibility relates to our recent finding that sub-lethal stress can
engage MOMP in a limited cohort of mitochondria without cell
death (Ichim et al, 2015). Whether MIMP and mtDNA release
occurs in these permeabilised mitochondria leading to cGAS-STING
activation is currently unclear.
Intense interest currently surrounds the pharmaceutical activa-
tion of cGAS-STING signalling to improve cancer immunotherapy
(Ng et al, 2018). Our own work has shown that engaging MOMP
under caspase-inhibited conditions—caspase-independent cell death
(CICD)—can potently activate anti-tumour immunity pathway
(Giampazolias et al, 2017). The inflammatory effects of CICD are
dependent on recognition of mtDNA by the cytosolic cGAS-STING
sensing pathway (Rongvaux et al, 2014; White et al, 2014;
Giampazolias et al, 2017). Underlying this effect, here we have
shown that following MOMP, the inner membrane is extruded via
BAX-mediated pores prior to permeabilisation and mtDNA release.
mtDNA-dependent activation of cGAS-STING has recently been
implicated in variety of pathophysiological processes including
infectious and inflammatory diseases (West & Shadel, 2017). As
such, further understanding the mechanism(s) of mtDNA mitochon-
drial release in different contexts may provide new avenues for
therapeutic exploitation.
◀ Figure 6. Mitochondrial inner membrane and mtDNA are extruded through BAX pores on the mitochondrial outer membrane.A Live-cell Airyscan images of U2OS BAX/BAK CRISPR-Cas9-deleted cells stably expressing JF646-MOM (magenta) and mCherry-BAX (cyan) and transiently expressing
TFAM-mClover (green). Cells were treated with 10 lM ABT-737, 2 lM S63845 and 20 lM qVD-OPh at t = 0. Scale bar = 10 lm. See Video EV10. Numbers indicate
time in minutes.
B Airyscan images of U2OS MCL1CRISPR cells stably expressing JF646-MOM (magenta) and transiently expressing TFAM-mClover (green), treated with 10 lM ABT-737 and
20 lM qVD-OPh for 3 h, immunostained with anti-active BAX (6A7, cyan). Images are maximum intensity projections of z-stack data. Scale bar = 10 lm.
Representative images from three independent experiments.
C Imaris 3D-rendering of U2OS cells as in (B) showing MOM (green), TFAM (red) and active BAX (cyan).
D U2OS cells stably expressing JF646-MOM (magenta) treated with 10 lM ABT-737, 2 lM S63845 and 20 lM qVD-OPh for 3 h. Cells were immunostained with
antibodies for active BAX (6A7, cyan) and AIF (IMM, green). Images are maximum intensity projections of z-stack data. Scale bar = 10 lm. Representative images from
three independent experiments.
E Imaris 3D-rendering of U2OS cells as in (D) showing MOM (green), AIF (red) and active BAX (cyan).
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Materials and Methods
Cell lines, plasmids, reagents and antibodies
U2OS, MEF, SVEC and 293FT were cultured in DMEM high-glucose
medium supplemented with 10% FCS, 2 mM glutamine, 1 mM
sodium pyruvate, 50 lM b-mercaptoethanol, penicillin (10,000
units/ml) and streptomycin (10,000 units/ml). Reagents used were
as followed: ABT-737, Q-VD-OPh (APEX Bio), S63845 (Active
Biochem) carbonyl cyanide 3-chlorophenylhydrazone (CCCP),
cyclosporin A (Sigma), actinomycin D (Merck). Cell lines were
routinely tested for the presence of mycoplasma. No cell lines were
authenticated, although SVEC cells were newly obtained from ATCC
(LGC Standards). To delete Drp1 from Drp1fl/fl MEFs, 2 × 106 cells
were seeded and infected with 200 MOI high titre Ad5CMVCre (Viral
Vector Core, University of Iowa) for 8 h, after which time the media
was removed and replaced. Cells were seeded the following day for
experiments. For CRISPR/Cas9-based genome editing, the following
sequences were cloned into LentiCRISPRv2-puro (Addgene #52961)
or LentiCRISPRv2-blasti (Lopez et al, 2016):
Human BAX: 50-AGTAGAAAAGGGCGACAACC-30
Human BAK: 50-GCCATGCTGGTAGACGTGTA-30
Human MCL1: 50-GGGTAGTGACCCGTCCGTAC-30
Mouse BAX: 50-CAACTTCAACTGGGGCCGCG-30
Mouse BAK: 50-GCGCTACGACACAGAGTTCC-30
Mouse STING #1: 50-CAGTAGTCCAAGTTCGTGCG-30
Mouse STING #2: 50-AGCGGTGACCTCTGGGCCGT-30
Mouse STING #3: 50-GTTAAATGTTGCCCACGGGC-30
For lentiviral and retroviral transduction, the following plasmids
were used: pLJM2 SNAP-Omp25 was obtained from Addgene
(#69599). mCherry-BAX was cloned into the pMx vector with blasti-
cidin resistance using Gibson assembly.
Transient expression vectors were generated as follows: pcDNA3
TFAM-mClover3 and pcDNA3 TFAM-mScarlet were cloned using
Gibson assembly (New England Biolabs) using TFAM-GFP (kind gift
from Mikhail Alexeyev, University of South Alabama (Pastukh et al,
2007), pKanCMV-mclover3-18aa-actin (Addgene #74259) and
pmScarlet-i_H2A_C1 (Addgene #85053) as templates. pcDNA3 AIF
(1-90)-mClover3 was cloned using Gibson assembly using pcDNA
AIF (1-90)-mCherry (Ichim et al, 2015) and pKanCMV-mclover3-
18aa-actin as templates.
Primary antibodies for Western blotting were as follows: rabbit
anti-BAX, rabbit anti-BAK, rabbit anti-DRP1, rabbit anti-STING (Cell
Signaling), mouse MitoProfile Membrane Integrity Cocktail (for
cyclophilin D; Abcam) and b-actin (Sigma). Primary antibodies for
immunofluorescence were as follows: rabbit anti-TOM20 (Santa
Cruz), mouse anti-DNA (Progen), rabbit anti-AIF, rabbit anti-TFAM
(Cell Signaling), mouse anti-cytochrome c (BD Transduction Labora-
tories), mouse anti-active BAX (6A7, Santa Cruz).
Stable cell line generation
For retroviral transduction, 293FT cells were transfected with 5 lg
of selected plasmid in combination with 1.2 lg gag/pol (Addgene
#14887) and 2.4 lg UVSVG (Addgene #12260) using Lipofectamine
2000 (Life Technologies). Viral supernatant was collected, filtered
and used to infect cells 24 and 48 h post-transfection in the presence
of 1 lg/ml Polybrene (Sigma-Aldrich). Cells were selected by
addition of 1 lg/ml puromycin (Sigma) or 10 lg/ml blasticidin
(InvivoGen) as appropriate. For cell lines stably overexpressing fluo-
rescent proteins, cells were FACS sorted to isolate a high-expressing
population.
For lentiviral transduction, 293FT cells were transfected with
5 lg of selected plasmid in combination with 1.86 lg psPAX2
(Addgene #8454) and 1 lg UVSVG (Addgene #12260) using Lipofec-
tamine 2000. Viral supernatant was collected, filtered and used to
infect cells 24 and 48 h post-transfection in the presence of 1 lg/ml
Polybrene. Cells were selected by addition of 1 lg/ml puromycin.
For cell lines stably overexpressing fluorescent proteins, cells were
FACS sorted to isolate a high-expressing population.
Clonogenic survival assay
U2OS cells were seeded at a density of 500 cells/well in 6-well plates
and left to adhere overnight. The following morning, cells were
treated as indicated and media replaced after 24 h. Cells were left to
grow and form colonies for 10 days before fixation with ice-cold
methanol and staining with crystal violet.
qRT–PCR
RNA was isolated from cells using GeneJET RNA Purification Kit
(Thermo Fisher Scientific) and included a DNase I treatment step
(Roche) to remove genomic DNA contamination. cDNA was gener-
ated from RNA using the High-Capacity cDNA Reverse Transcription
kit (Thermo Fisher Scientific). PCR was performed on a Bio-Rad
C1000 Thermal Cycler using the following conditions: 3 min at
95°C, 40 cycles of 20 s at 95°C, 30 s at 57°C, 30 s at 72°C and a final
5 min at 72°C using the Brilliant III Ultra-Fast SYBR Green qPCR
Master Mix (Agilent Technologies). mRNA quantification was anal-
ysed using the 2DDCT methods. Primer sequences used are as
follows:
Mouse Ifnb1-F: AACTCCACCAGCAGACAGTG
Mouse Ifnb1-R: AGTGGAGAGCAGTTGAGGAC
Mouse Irf7-F: TTTGGAGACTGGCTATTGGGG
Mouse Irf7-R: CCTACGACCGAAATGCTTCCA
Mouse Oasl1-F: CATGCTCCCAAGCTTCTCTCT
Mouse Oasl1-R: CTGCCATGGCTCCTCCTTTTT
Mouse Actin-F: CACTGTCGAGTCGCGTCC
Mouse Actin-R: GTCATCCATGGCGAACTGGT
Microscopy
Cells were fixed in 4% PFA/PBS for 10 min, followed by permeabili-
sation in 0.2% Triton X-100/PBS for 15 min, followed by blocking
in 2% BSA/PBS for 1 h. Cells were incubated with primary antibod-
ies overnight in a humidified chamber at 4°C followed by extensive
washing before addition of secondary antibodies for 1 h at room
temperature. Secondary antibodies used for detection were as
follows: Alexa Fluor 488 goat anti-mouse (A11029), Alexa Fluor 488
goat anti-rabbit (A11034), Alexa Fluor 568 goat anti-mouse
(A11004), Alexa Fluor 568 goat anti-rabbit (A11011), Alexa Fluor
647 goat anti-mouse (A21236), Alexa Fluor 647 goat anti-rabbit
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(A21245); all purchased from Life Technologies. Slides were
mounted in Vectashield antifade aqueous mounting medium
(Vector Laboratories), with or without DAPI. For triple colour anti-
body-based immunofluorescence, cells were co-incubated with two
antibodies (typically TOM20 and DNA), thoroughly washed and
incubated with Alexa Fluor 488/568 secondary antibodies. Follow-
ing extensive washing, cells were blocked with 5% mouse serum
(Life Technologies) for 1 h at room temperature and further incu-
bated with cytochrome c directly conjugated to Alexa Fluor 647
(clone 6H2.B4, Biolegend).
Airyscan imaging
Super-resolution Airyscan images were acquired on a Zeiss LSM 880
with Airyscan microscope (Carl Zeiss). Samples were prepared on
high precision cover glass (Zeiss, Germany). Data were collected
using a 63 × 1.4 NA objective for the majority of experiments,
except for calcein-AM experiments where the 40× (1.3 NA) objec-
tive was used; 488, 561 and 640 nm laser lines were used, and
refractive index-matched immersion oil (Zeiss) was used for all
experiments. Where z-stacks were collected, the software-recom-
mended optimal slice sizes were used. For both fixed-cell and live-
cell experiments, colours were collected sequentially in order to
minimise bleedthrough. Live-cell experiments were performed in an
environmental chamber to allow maintenance of 37°C temperature
and 5% CO2. Airyscan processing was performed using the Airyscan
processing function in the ZEN software. To maintain clarity and
uniformity throughout the paper, some images have been pseudo-
coloured.
3D-SIM imaging
3D structured illumination microscopy (3D-SIM) images were
acquired on a Nikon N-SIM microscope (Nikon Instruments, UK).
Samples were prepared on high precision cover glass (Zeiss,
Germany). Data were collected using a Nikon Plan Apo TIRF
100 × 1.49 NA objective and an Andor DU-897X-5254 camera
using 488, 561 and 640 nm laser lines. Refractive index-matched
immersion oil (Nikon Instruments) was used for all experiments.
Z-stacks were collected with a step size of 120 nm as required by
the manufacturer software. For each focal plane, 15 images were
acquired (five phases, three angles) and captured using the NiS-
Elements software. SIM image processing, reconstruction and anal-
ysis were carried out using the N-SIM module of the NiS-Elements
Advanced Research software. Images were checked for artefacts
using the SIMcheck software (http://www.micron.ox.ac.uk/software/
SIMCheck.php). Images were reconstructed using NiS-Elements
software v4.6 (Nikon Instruments, Japan) from a z-stack compris-
ing of no < 1 lm of optical sections. In all SIM image reconstruc-
tions, the Wiener and Apodization filter parameters were kept
constant.
3D renderings, mtDNA release quantification and image analysis
Acquired z-stacks were imported into Imaris (Bitplane, Oxford
Instruments, Switzerland). To segment inner mitochondrial
membrane (IMM) and mtDNA nucleoids, a surface was creating
using the IMM channel. Masks were applied to differentiate between
mtDNA nucleoids inside and outside the surface (i.e. in or out of the
IMM). From these masks, spots were created from the mtDNA
channel.
For quantification of mtDNA outside the mitochondrial outer
mitochondrial (MOM), a surface was created for the MOM channel.
Spots were then generated from the mtDNA channel, and the trans-
parency of the MOM surface altered to allow visualisation of mtDNA
nucleoid spots outside or inside the MOM. Cells were visually
scored to quantitate the degree of mtDNA release.
All images were analysed in ImageJ, including maximum inten-
sity projections, before figure panels were assembled in Adobe Illus-
trator. Omi release was assessed by the standard deviation of the
Omi signal across a cell in ImageJ. Mitochondria pore size was
measured using the ruler tool in ImageJ.
SNAP-tag labelling
Cell lines stably expressing pLJM2 SNAP-Omp25 were incubated
with 15 nM JF646 SNAP ligand (kind gift from Luke Lavis) for
30 min in complete medium. Throughout the paper, we refer to
MOM labelled in this manner as JF646-MOM. Cells were washed
three times in medium and returned to the incubator for 15 min to
allow any unbound dye to diffuse out. Media was replaced with
FluoroBrite DMEM (Life Technologies) supplemented with 10%
FCS, 2 mM glutamine and 1 mM sodium pyruvate and then imaged.
Calcein-AM assay
Mitochondria inner membrane permeabilisation was assessed using
a modified version of the calcein-AM/cobalt assay described by
Bonora et al (2016). Briefly, U2OS cells stably expressing JF646-
MOM and Omi-mCherry were cells seeded onto coverglass dishes to
70% confluency. Cells were incubated with 1 lM of calcein-AM
stock solution and 10 mM CoCl2 in HBSS supplemented with
10 mM HEPES and 2 ml L-glutamine for 15 min at 37°C in a 5%
CO2 atmosphere. Cells were washed twice in HBSS, and then,
900 ll of supplemented HBSS and 10 mM CoCl2 was added. Cells
were left to acclimatise in the microscope environmental chamber
for 30 min and imaged following addition of inducers of apoptosis,
qVD-OPh  cyclosporin A.
Western blotting
Cells were lysed in NP-40 lysis buffer (1% NP-40, 1 mM EDTA,
150 mM NaCl, 50 mM Tris–Cl pH 7.4) supplemented with complete
protease inhibitor (Roche). Protein concentration was determined
by Bradford assay (Bio-Rad). Protein lysates were subjected to elec-
trophoresis through 10 or 12% SDS–PAGE gels and transferred onto
nitrocellulose membrane. Membranes were blocked in 5% milk/
PBS-Tween for 1 h at room temperature and incubated with primary
antibody over night at 4°C in blocking buffer. Following washing,
membranes were incubated with Li-Cor secondary antibodies
(IRDye 680RD donkey anti-mouse or IRDye 800CW donkey anti-
rabbit) for 1 h at room temperature and protein levels detected
using a Li-Cor Odyssey CLx (Li-Cor) and acquired using Image-
Studio (Li-Cor). Resulting images were minimally processed for clar-
ity and arranged using Adobe Illustrator.
Live-cell viability assays
Cell viability was assayed using an IncuCyte FLR imaging system
(Sartorius). Briefly, cells were seeded overnight and drugged in the
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presence of 30 nM SYTOX Green (Life Technologies), a non-cell-
permeable nuclear stain. Where the same cell line was compared,
SYTOX Green-positivity was compared directly; where different cell
lines (e.g. WT and KO MEFs) were compared, data were normalised
to starting confluency. All quantification was performed using the
IncuCyte software.
Expanded View for this article is available online.
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